Symbols / TGTX Stock $38.28 -0.08% TG Therapeutics, Inc.

Healthcare • Biotechnology • United States • NCM
TGTX (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
About

TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell mediated diseases in the United States and internationally. The company provides BRIUMVI, an anti-CD20 monoclonal antibody for the treatment of adult patients with relapsing forms of multiple sclerosis (RMS), including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease in adults. The company's development pipeline comprises Ublituximab IV, glycoengineered anti-CD20 mAb for the treatment of relapsing MS; TG-1701 is an orally available and covalently bound Bruton's tyrosine kinase (BTK) inhibitor that exhibits selectivity to BTK in vitro kinase screening; and TG-1801, a bispecific CD47 and CD19 antibody. Its research pipeline includes various investigational medicines. The company has license agreements with LFB Biotechnologies S.A.S; GTC Biotherapeutics; LFB/GTC LLC; Ildong Pharmaceutical Co. Ltd.; and Jiangsu Hengrui Medicine Co. The company was incorporated in 1993 and is based in Morrisville, North Carolina.

Stock Fundamentals
Scroll to Statements
Market Cap 6.11B Enterprise Value 5.77B Income 447.18M Sales 616.29M Book/sh 4.52 Cash/sh 0.96
Dividend Yield — Payout 0.00% Employees 399 IPO — P/E 13.82 Forward P/E 16.11
PEG 1.61 P/S 9.92 P/B 8.47 P/C — EV/EBITDA 46.76 EV/Sales 9.36
Quick Ratio 2.91 Current Ratio 4.10 Debt/Eq 39.26 LT Debt/Eq — EPS (ttm) 2.77 EPS next Y 2.38
EPS Growth -6.10% Revenue Growth 78.00% Earnings 2026-05-04 ROA 9.39% ROE 102.75% ROIC —
Gross Margin 83.66% Oper. Margin 26.22% Profit Margin 72.56% Shs Outstand 159.69M Shs Float 140.95M Short Float 23.66%
Short Ratio 13.58 Short Interest — 52W High 46.48 52W Low 25.28 Beta 1.75 Avg Volume 1.86M
Volume 184.80K Target Price $44.57 Recom Buy Prev Close $38.31 Price $38.28 Change -0.08%
Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$44.57
Mean price target
2. Current target
$38.28
Latest analyst target
3. DCF / Fair value
$-4.96
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$38.28
Low
$15.00
High
$60.00
Mean
$44.57

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-02-02 main JP Morgan Overweight → Overweight $46
2026-01-15 main Goldman Sachs Neutral → Neutral $39
2025-11-03 main JP Morgan Overweight → Overweight $49
2025-09-17 main B. Riley Securities Buy → Buy $55
2025-03-04 reit HC Wainwright & Co. Buy → Buy $55
2025-01-15 reit HC Wainwright & Co. Buy → Buy $55
2024-11-25 main JP Morgan Overweight → Overweight $43
2024-11-05 main HC Wainwright & Co. Buy → Buy $55
2024-11-05 main Goldman Sachs Neutral → Neutral $22
2024-10-29 init TD Cowen — → Buy $50
2024-09-18 reit HC Wainwright & Co. Buy → Buy $49
2024-08-07 main B. Riley Securities Buy → Buy $34
2024-08-07 main Goldman Sachs Neutral → Neutral $20
2024-08-06 reit HC Wainwright & Co. Buy → Buy $49
2024-05-02 main HC Wainwright & Co. Buy → Buy $49
2024-05-02 main Ladenburg Thalmann Buy → Buy $40
2024-04-18 reit HC Wainwright & Co. Buy → Buy $45
2024-04-18 reit JP Morgan Overweight → Overweight $25
2024-04-18 reit Ladenburg Thalmann Buy → Buy $39
2024-03-01 reit HC Wainwright & Co. Buy → Buy $45
News
RSS: Latest TGTX news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-01-29 CHARNEY LAURENCE NEIL Director — 43,197 $0.00 $0
2026-01-08 WEISS MICHAEL S Chief Executive Officer — 622,000 $0.00 $0
2026-01-08 POWER SEAN A Chief Financial Officer — 90,000 $0.00 $0
2025-11-24 ECHELARD YANN Director — 5,000 $32.57 $162,850
2025-11-05 WEISS MICHAEL S Chief Executive Officer — 4,668,843 $0.00 $0
2025-09-11 LONIAL SAGAR Director — 20,852 $32.24 $672,268
2025-06-13 ECHELARD YANN Director — 10,000 $36.94 $369,400
2025-06-12 HUME DANIEL Director — 14,718 $0.00 $0
2025-06-12 LONIAL SAGAR Director — 14,718 $0.00 $0
2025-06-12 CHARNEY LAURENCE NEIL Director — 21,408 $0.00 $0
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
616.29
+87.32%
329.00
+40.80%
233.66
+8290.02%
2.79
Operating Revenue
616.29
+87.32%
329.00
+40.80%
233.66
+8290.02%
2.79
Cost Of Revenue
100.71
+161.69%
38.49
+172.35%
14.13
+5232.45%
0.27
Reconciled Cost Of Revenue
100.71
+161.69%
38.49
+172.35%
14.13
+5232.45%
0.27
Gross Profit
515.57
+77.47%
290.52
+32.34%
219.53
+8611.55%
2.52
Operating Expense
392.25
+57.79%
248.59
+24.98%
198.90
-9.93%
220.84
Research And Development
160.22
+69.92%
94.29
+23.75%
76.19
-39.22%
125.35
Selling General And Administration
232.03
+50.38%
154.30
+25.75%
122.71
+28.51%
95.48
Selling And Marketing Expense
—
—
—
64.05
General And Administrative Expense
232.03
+50.38%
154.30
+25.75%
122.71
+28.51%
95.48
Salaries And Wages
48.05
+53.13%
31.38
+25.91%
24.92
-20.72%
31.44
Other Gand A
183.98
+49.68%
122.92
+25.70%
97.78
+52.68%
64.05
Total Expenses
492.96
+71.72%
287.07
+34.76%
213.03
-3.65%
221.10
Operating Income
123.32
+194.13%
41.93
+103.21%
20.63
+109.45%
-218.32
Total Operating Income As Reported
123.32
+194.13%
41.93
+103.21%
20.63
+109.45%
-218.32
EBITDA
134.36
+169.25%
49.90
+91.20%
26.10
+112.25%
-213.11
Normalized EBITDA
134.36
+169.25%
49.90
+91.20%
26.10
+112.25%
-213.11
Reconciled Depreciation
0.24
-12.86%
0.28
-33.81%
0.42
-17.86%
0.52
EBIT
134.12
+170.28%
49.62
+93.25%
25.68
+112.02%
-213.62
Net Income
447.18
+1812.41%
23.38
+84.52%
12.67
+105.66%
-223.81
Pretax Income
107.39
+319.59%
25.59
+95.94%
13.06
+105.84%
-223.81
Net Non Operating Interest Income Expense
-26.73
-11.23%
-24.03
-90.47%
-12.62
-23.79%
-10.19
Interest Expense Non Operating
26.73
+11.23%
24.03
+90.47%
12.62
+23.79%
10.19
Net Interest Income
-26.73
-11.23%
-24.03
-90.47%
-12.62
-23.79%
-10.19
Interest Expense
26.73
+11.23%
24.03
+90.47%
12.62
+23.79%
10.19
Other Income Expense
10.79
+40.30%
7.69
+52.52%
5.04
+7.43%
4.70
Other Non Operating Income Expenses
10.79
+40.30%
7.69
+52.52%
5.04
+7.43%
4.70
Tax Provision
-339.79
-15468.11%
2.21
+466.92%
0.39
0.00
Tax Rate For Calcs
0.00
+143.09%
0.00
+189.33%
0.00
0.00
Tax Effect Of Unusual Items
0.00
0.00
0.00
0.00
Net Income Including Noncontrolling Interests
447.18
+1812.41%
23.38
+84.52%
12.67
+105.66%
-223.81
Net Income From Continuing Operation Net Minority Interest
447.18
+1812.41%
23.38
+84.52%
12.67
+105.66%
-223.81
Net Income From Continuing And Discontinued Operation
447.18
+1812.41%
23.38
+84.52%
12.67
+105.66%
-223.81
Net Income Continuous Operations
447.18
+1812.41%
23.38
+84.52%
12.67
+105.66%
-223.81
Normalized Income
447.18
+1812.41%
23.38
+84.52%
12.67
+105.66%
-223.81
Net Income Common Stockholders
447.18
+1812.41%
23.38
+84.52%
12.67
+105.66%
-223.81
Diluted EPS
2.77
+1746.67%
0.15
+66.67%
0.09
+106.16%
-1.46
Basic EPS
3.10
+1837.50%
0.16
+77.78%
0.09
+106.16%
-1.46
Basic Average Shares
144.32
-0.69%
145.32
+2.37%
141.96
+4.83%
135.41
Diluted Average Shares
161.41
+0.67%
160.34
+7.96%
148.51
+9.67%
135.41
Diluted NI Availto Com Stockholders
447.18
+1812.41%
23.38
+84.52%
12.67
+105.66%
-223.81
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
1,063.25
+84.05%
577.69
+75.28%
329.59
+70.27%
193.57
Current Assets
630.76
+11.37%
566.36
+78.13%
317.94
+88.94%
168.27
Cash Cash Equivalents And Short Term Investments
141.97
-54.35%
311.00
+42.98%
217.51
+34.53%
161.68
Cash And Cash Equivalents
79.15
-56.00%
179.89
+93.57%
92.93
-9.16%
102.30
Other Short Term Investments
62.82
-52.08%
131.11
+5.24%
124.58
+109.81%
59.37
Receivables
305.63
+136.58%
129.19
+152.84%
51.09
0.00
Accounts Receivable
305.63
+136.58%
129.19
+152.84%
51.09
0.00
Inventory
125.59
+13.70%
110.46
+177.37%
39.82
0.00
Prepaid Assets
—
—
4.18
-1.27%
4.24
Other Current Assets
57.58
+266.38%
15.72
+65.10%
9.52
+303.52%
2.36
Total Non Current Assets
432.49
+3716.87%
11.33
-2.69%
11.64
-53.97%
25.30
Net PPE
6.28
-12.21%
7.15
-11.17%
8.05
-25.61%
10.82
Gross PPE
6.28
-12.21%
7.15
-11.17%
8.05
-25.61%
10.82
Properties
—
—
0.00
0.00
Other Properties
6.28
-12.21%
7.15
-11.17%
8.05
-12.45%
9.20
Leases
—
—
1.42
-13.03%
1.63
Goodwill And Other Intangible Assets
—
—
0.80
+0.00%
0.80
Goodwill
—
—
0.80
+0.00%
0.80
Investments And Advances
74.83
+9160.52%
0.81
0.00
-100.00%
12.40
Long Term Equity Investment
15.69
0.00
—
—
Non Current Deferred Assets
348.00
0.00
—
—
Non Current Deferred Taxes Assets
348.00
0.00
—
—
Other Non Current Assets
3.39
+0.42%
3.37
-6.18%
3.59
+182.33%
1.27
Total Liabilities Net Minority Interest
415.23
+16.86%
355.33
+110.15%
169.09
+25.26%
134.99
Current Liabilities
153.76
+69.57%
90.68
+68.80%
53.72
+0.98%
53.20
Payables And Accrued Expenses
107.51
+84.42%
58.30
+51.53%
38.47
-8.44%
42.02
Pensionand Other Post Retirement Benefit Plans Current
21.85
+43.89%
15.19
+24.75%
12.17
+44.35%
8.43
Current Debt And Capital Lease Obligation
1.04
-9.77%
1.16
-19.99%
1.45
-8.54%
1.58
Current Debt
—
—
—
—
Other Current Borrowings
—
—
—
—
Current Capital Lease Obligation
1.04
-9.77%
1.16
-19.99%
1.45
-8.54%
1.58
Current Deferred Liabilities
21.23
+86.03%
11.41
+7409.21%
0.15
—
Current Deferred Revenue
21.23
+86.03%
11.41
+7409.21%
0.15
—
Other Current Liabilities
2.12
-54.10%
4.63
+212.85%
1.48
+26.52%
1.17
Total Non Current Liabilities Net Minority Interest
261.47
-1.20%
264.65
+129.40%
115.36
+41.06%
81.78
Long Term Debt And Capital Lease Obligation
252.67
+0.04%
252.56
+130.97%
109.35
+34.21%
81.48
Long Term Debt
245.65
+0.50%
244.43
+144.14%
100.12
+40.74%
71.14
Long Term Capital Lease Obligation
7.02
-13.67%
8.13
-11.89%
9.23
-10.76%
10.34
Non Current Deferred Liabilities
8.81
-27.12%
12.09
+100.88%
6.02
+1872.46%
0.30
Non Current Deferred Revenue
8.81
-27.12%
12.09
+100.88%
6.02
+1872.46%
0.30
Stockholders Equity
648.02
+191.42%
222.36
+38.54%
160.50
+173.95%
58.59
Common Stock Equity
648.02
+191.42%
222.36
+38.54%
160.50
+173.95%
58.59
Capital Stock
0.16
+1.92%
0.16
+3.31%
0.15
+3.42%
0.15
Common Stock
0.16
+1.92%
0.16
+3.31%
0.15
+3.42%
0.15
Share Issued
158.85
+1.69%
156.20
+3.13%
151.47
+3.44%
146.43
Ordinary Shares Number
155.31
-0.34%
155.84
+2.91%
151.42
+3.44%
146.39
Treasury Shares Number
3.54
+863.20%
0.37
+790.61%
0.04
+0.00%
0.04
Additional Paid In Capital
1,830.11
+3.96%
1,760.40
+2.76%
1,713.16
+8.04%
1,585.71
Retained Earnings
-1,082.02
+29.24%
-1,529.19
+1.51%
-1,552.58
-1.67%
-1,527.03
Treasury Stock
100.23
+1014.45%
8.99
+3743.59%
0.23
+0.00%
0.23
Total Equity Gross Minority Interest
648.02
+191.42%
222.36
+38.54%
160.50
+173.95%
58.59
Total Capitalization
893.66
+91.45%
466.79
+79.11%
260.62
+100.91%
129.72
Working Capital
477.00
+0.28%
475.68
+80.03%
264.22
+129.61%
115.07
Invested Capital
893.66
+91.45%
466.79
+79.11%
260.62
+100.91%
129.72
Total Debt
253.71
0.00%
253.72
+129.00%
110.80
+33.39%
83.06
Net Debt
166.50
+157.99%
64.53
+798.19%
7.18
—
Capital Lease Obligations
8.06
-13.19%
9.29
-12.99%
10.68
-10.47%
11.93
Net Tangible Assets
648.02
+191.42%
222.36
+38.54%
160.50
+177.74%
57.79
Tangible Book Value
648.02
+191.42%
222.36
+38.54%
160.50
+177.74%
57.79
Held To Maturity Securities
59.14
+7218.81%
0.81
0.00
-100.00%
12.40
Investmentin Financial Assets
59.14
+7218.81%
0.81
0.00
-100.00%
12.40
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
-24.77
+38.86%
-40.52
-28.98%
-31.41
+82.17%
-176.17
Cash Flow From Continuing Operating Activities
-24.77
+38.86%
-40.52
-28.98%
-31.41
+82.17%
-176.17
Net Income From Continuing Operations
447.18
+1812.41%
23.38
+84.52%
12.67
+105.66%
-223.81
Depreciation Amortization Depletion
0.24
-12.86%
0.28
-33.81%
0.42
-17.86%
0.52
Depreciation
0.24
-12.86%
0.28
-33.81%
0.42
-17.86%
0.52
Depreciation And Amortization
0.24
-12.86%
0.28
-33.81%
0.42
-17.86%
0.52
Other Non Cash Items
2.99
-28.77%
4.20
-5.73%
4.45
+0.25%
4.44
Stock Based Compensation
64.67
+52.02%
42.54
+12.15%
37.93
-15.07%
44.66
Provisionand Write Offof Assets
6.17
0.00
0.00
—
Deferred Tax
-348.00
0.00
0.00
—
Deferred Income Tax
-348.00
0.00
0.00
—
Operating Gains Losses
—
4.61
—
—
Unrealized Gain Loss On Investment Securities
0.30
-60.48%
0.75
0.00
0.00
Change In Working Capital
-194.54
-77.99%
-109.30
-29.10%
-84.66
-5040.19%
-1.65
Change In Receivables
-176.44
-125.94%
-78.09
-52.84%
-51.09
-3778.40%
1.39
Changes In Account Receivables
-176.44
-125.94%
-78.09
-52.84%
-51.09
-3778.40%
1.39
Change In Inventory
-33.45
+49.96%
-66.85
-80.98%
-36.94
0.00
Change In Payables And Accrued Expense
55.88
+144.67%
22.84
+11794.79%
0.19
+101.74%
-11.01
Change In Other Working Capital
6.39
-63.45%
17.48
+206.13%
5.71
+3857.24%
-0.15
Change In Other Current Assets
-42.43
-571.79%
-6.32
-123.10%
-2.83
-134.60%
8.18
Change In Other Current Liabilities
-4.48
-373.00%
1.64
+447.00%
0.30
+645.45%
-0.06
Investing Cash Flow
13.80
+1431.95%
-1.04
+97.95%
-50.65
-153.09%
-20.01
Cash Flow From Continuing Investing Activities
13.80
+1431.95%
-1.04
+97.95%
-50.65
-153.09%
-20.01
Net PPE Purchase And Sale
-0.21
-375.56%
-0.04
0.00
+100.00%
-0.01
Purchase Of PPE
-0.21
-375.56%
-0.04
0.00
+100.00%
-0.01
Capital Expenditure
-0.21
-375.56%
-0.04
—
-0.01
Net Investment Purchase And Sale
14.01
+1514.03%
-0.99
+98.04%
-50.65
-153.27%
-20.00
Purchase Of Investment
-223.49
+28.34%
-311.89
-112.34%
-146.88
-36.92%
-107.27
Sale Of Investment
237.50
-23.61%
310.90
+223.08%
96.23
+10.26%
87.28
Financing Cash Flow
-89.73
-169.81%
128.53
+76.78%
72.70
+18694.63%
-0.39
Cash Flow From Continuing Financing Activities
-89.73
-169.81%
128.53
+76.78%
72.70
+18694.63%
-0.39
Net Issuance Payments Of Debt
0.00
-100.00%
137.26
+449.05%
25.00
+2664.10%
-0.97
Issuance Of Debt
0.00
-100.00%
244.81
+879.26%
25.00
0.00
Repayment Of Debt
0.00
+100.00%
-107.55
0.00
+100.00%
-0.97
Long Term Debt Issuance
0.00
-100.00%
244.81
+879.26%
25.00
0.00
Long Term Debt Payments
0.00
+100.00%
-107.55
0.00
+100.00%
-0.97
Net Long Term Debt Issuance
0.00
-100.00%
137.26
+449.05%
25.00
+2664.10%
-0.97
Net Common Stock Issuance
-91.24
-941.55%
-8.76
-118.92%
46.30
0.00
Common Stock Payments
-91.24
-941.55%
-8.76
0.00
0.00
Cash Dividends Paid
—
—
—
—
Repurchase Of Capital Stock
-91.24
-941.55%
-8.76
0.00
0.00
Proceeds From Stock Option Exercised
1.51
+65.32%
0.91
-40.42%
1.53
+162.67%
0.58
Net Other Financing Charges
—
-0.89
-611.20%
-0.12
—
Changes In Cash
-100.70
-215.78%
86.97
+1029.31%
-9.36
+95.24%
-196.57
Beginning Cash Position
181.19
+92.31%
94.22
-9.04%
103.58
-65.49%
300.15
End Cash Position
80.49
-55.58%
181.19
+92.31%
94.22
-9.04%
103.58
Free Cash Flow
-24.99
+38.40%
-40.56
-29.12%
-31.41
+82.17%
-176.18
Interest Paid Supplemental Data
24.25
+31.29%
18.47
+110.58%
8.77
+61.08%
5.45
Income Tax Paid Supplemental Data
7.88
+1475.80%
0.50
0.00
0.00
Amortization Of Securities
-3.79
+45.76%
-6.98
-212.34%
-2.24
-575.53%
-0.33
Common Stock Issuance
0.00
0.00
-100.00%
46.30
0.00
Interest Paid CFF
—
—
—
—
Issuance Of Capital Stock
0.00
0.00
-100.00%
46.30
0.00
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category